The Food and Drug Administration last week issued an emergency use authorization to Becton, Dickinson and Company for its sodium citrate blood specimen collection tubes for coagulation testing by authorized laboratories for COVID-19 and other patients. For more information, see the FDA fact sheet. Sodium citrate blood specimen collection tubes have been on the FDA’s device shortage list since last month. 

Related News Articles

Headline
The Centers for Disease Control and Prevention yesterday alerted health care providers and the public to reports of severe illness associated with using…
Headline
Health care providers should stop using N95 respirators made by Shanghai Dasheng Health Products Manufacturing Co. Ltd., which are no longer authorized for…
Headline
The Centers for Disease Control and Prevention today released research highlighting two important trends emerging from the COVID-19 pandemic regarding vaccines…
Headline
The Centers for Medicare & Medicaid Services today issued a Health Plan Management System memo to all Medicare Advantage Organizations and Medicare-…
Headline
In evaluating whether to temporarily suspend survey activities if a hospital experiences a COVID-19 surge, the Centers for Medicare & Medicaid Services in…
Headline
Centers for Disease Control and Prevention Director Rochelle Walensky, M.D., late Friday authorized a third, additional dose of the mRNA COVID-19 vaccines…